vs
Side-by-side financial comparison of Gogo Inc. (GOGO) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $230.6M, roughly 1.3× Gogo Inc.). Bio-Techne runs the higher net margin — 12.8% vs -4.3%, a 17.2% gap on every dollar of revenue. On growth, Gogo Inc. posted the faster year-over-year revenue change (67.3% vs -6.4%). Over the past eight quarters, Gogo Inc.'s revenue compounded faster (48.7% CAGR vs 4.2%).
Gogo Inc. is an American provider of in-flight broadband Internet service and other connectivity services for business aircraft, headquartered in Broomfield, Colorado. Through its Gogo LLC subsidiary, Gogo previously provided in-flight WiFi to 17 airlines until the Commercial Air business was sold to Intelsat for $400 million in December 2020. According to Gogo, over 2,500 commercial aircraft and 6,600 business aircraft have been equipped with its onboard Wi-Fi services. The company is the de...
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
GOGO vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $230.6M | $295.9M |
| Net Profit | $-10.0M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | 6.2% | 18.4% |
| Net Margin | -4.3% | 12.8% |
| Revenue YoY | 67.3% | -6.4% |
| Net Profit YoY | 64.6% | 68.3% |
| EPS (diluted) | $-0.08 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $230.6M | $295.9M | ||
| Q3 25 | $223.6M | — | ||
| Q2 25 | $226.0M | $317.0M | ||
| Q1 25 | $230.3M | $316.2M | ||
| Q4 24 | $137.8M | $297.0M | ||
| Q3 24 | $100.5M | $289.5M | ||
| Q2 24 | $102.1M | $306.1M | ||
| Q1 24 | $104.3M | $303.4M |
| Q4 25 | $-10.0M | $38.0M | ||
| Q3 25 | $-1.9M | — | ||
| Q2 25 | $12.8M | $-17.7M | ||
| Q1 25 | $12.0M | $22.6M | ||
| Q4 24 | $-28.2M | $34.9M | ||
| Q3 24 | $10.6M | $33.6M | ||
| Q2 24 | $839.0K | $40.6M | ||
| Q1 24 | $30.5M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | 87.8% | 62.7% | ||
| Q1 25 | 87.3% | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | 6.2% | 18.4% | ||
| Q3 25 | 12.9% | — | ||
| Q2 25 | 15.9% | -7.5% | ||
| Q1 25 | 15.3% | 12.2% | ||
| Q4 24 | -17.5% | 16.0% | ||
| Q3 24 | 19.0% | 13.8% | ||
| Q2 24 | 21.2% | 15.0% | ||
| Q1 24 | 33.2% | 22.1% |
| Q4 25 | -4.3% | 12.8% | ||
| Q3 25 | -0.9% | — | ||
| Q2 25 | 5.7% | -5.6% | ||
| Q1 25 | 5.2% | 7.1% | ||
| Q4 24 | -20.5% | 11.7% | ||
| Q3 24 | 10.6% | 11.6% | ||
| Q2 24 | 0.8% | 13.3% | ||
| Q1 24 | 29.2% | 16.2% |
| Q4 25 | $-0.08 | $0.24 | ||
| Q3 25 | $-0.01 | — | ||
| Q2 25 | $0.09 | $-0.11 | ||
| Q1 25 | $0.09 | $0.14 | ||
| Q4 24 | $-0.22 | $0.22 | ||
| Q3 24 | $0.08 | $0.21 | ||
| Q2 24 | $0.01 | $0.26 | ||
| Q1 24 | $0.23 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $125.2M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $101.1M | $2.0B |
| Total Assets | $1.3B | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $125.2M | $172.9M | ||
| Q3 25 | $133.6M | — | ||
| Q2 25 | $102.1M | $162.2M | ||
| Q1 25 | $70.3M | $140.7M | ||
| Q4 24 | $41.8M | $177.5M | ||
| Q3 24 | $176.7M | $187.5M | ||
| Q2 24 | $161.6M | $152.9M | ||
| Q1 24 | $152.8M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $101.1M | $2.0B | ||
| Q3 25 | $107.0M | — | ||
| Q2 25 | $102.8M | $1.9B | ||
| Q1 25 | $82.9M | $2.0B | ||
| Q4 24 | $69.3M | $2.1B | ||
| Q3 24 | $52.7M | $2.1B | ||
| Q2 24 | $52.0M | $2.1B | ||
| Q1 24 | $62.4M | $2.0B |
| Q4 25 | $1.3B | $2.5B | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | $2.6B | ||
| Q1 25 | $1.2B | $2.6B | ||
| Q4 24 | $1.2B | $2.7B | ||
| Q3 24 | $810.7M | $2.7B | ||
| Q2 24 | $802.7M | $2.7B | ||
| Q1 24 | $809.0M | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.5M | — |
| Free Cash FlowOCF − Capex | $-25.4M | — |
| FCF MarginFCF / Revenue | -11.0% | — |
| Capex IntensityCapex / Revenue | 14.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $65.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.5M | — | ||
| Q3 25 | $46.8M | — | ||
| Q2 25 | $36.7M | $98.2M | ||
| Q1 25 | $32.5M | $41.1M | ||
| Q4 24 | $-38.3M | $84.3M | ||
| Q3 24 | $25.1M | $63.9M | ||
| Q2 24 | $24.9M | $75.5M | ||
| Q1 24 | $29.7M | $81.0M |
| Q4 25 | $-25.4M | — | ||
| Q3 25 | $27.3M | — | ||
| Q2 25 | $33.5M | $93.3M | ||
| Q1 25 | $29.7M | $31.0M | ||
| Q4 24 | $-42.6M | $77.5M | ||
| Q3 24 | $20.7M | $54.7M | ||
| Q2 24 | $21.6M | $57.5M | ||
| Q1 24 | $28.2M | $64.5M |
| Q4 25 | -11.0% | — | ||
| Q3 25 | 12.2% | — | ||
| Q2 25 | 14.8% | 29.4% | ||
| Q1 25 | 12.9% | 9.8% | ||
| Q4 24 | -30.9% | 26.1% | ||
| Q3 24 | 20.6% | 18.9% | ||
| Q2 24 | 21.1% | 18.8% | ||
| Q1 24 | 27.0% | 21.3% |
| Q4 25 | 14.7% | — | ||
| Q3 25 | 8.7% | — | ||
| Q2 25 | 1.4% | 1.5% | ||
| Q1 25 | 1.2% | 3.2% | ||
| Q4 24 | 3.1% | 2.3% | ||
| Q3 24 | 4.4% | 3.2% | ||
| Q2 24 | 3.3% | 5.9% | ||
| Q1 24 | 1.4% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.87× | — | ||
| Q1 25 | 2.70× | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | 2.36× | 1.90× | ||
| Q2 24 | 29.74× | 1.86× | ||
| Q1 24 | 0.97× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GOGO
| Services | $191.9M | 83% |
| Products | $38.7M | 17% |
| Fcc Reimbursement Program | $2.0M | 1% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
